Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Neural Tube Defects?
NCT ID: NCT04135274
Last Updated: 2019-10-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
57 participants
OBSERVATIONAL
2015-01-01
2018-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neonatal Sepsis Diagnosis: ; PCR Commercial Technique and Blood Culture
NCT03884894
Utility of Placental/Umbilical Cord Blood in Early Onset Neonatal Sepsis in Very Low Birth Weight Infants
NCT03694613
Characteristics of Cord Blood Immunologic Parameters of Infants <32 Weeks Gestation
NCT00524394
Does Modified Ultrafiltration Affect Thromboelastography Results?
NCT03214120
THE VALUE OF INTERLEUKIN 6 AS A DIAGNOSTIC MARKER IN NEONATAL SEPSIS
NCT05585957
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sepsis group
Neutrophil to lymphocyte ratio
Neutrophil to lymphocyte ratio
Non Sepsis group
Neutrophil to lymphocyte ratio
Neutrophil to lymphocyte ratio
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neutrophil to lymphocyte ratio
Neutrophil to lymphocyte ratio
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
28 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tepecik Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Firat Ergin
Medical Doctor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018/12- 7
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.